Search for Clinical Trial Results

Sponsored By

Graft vs Host Disease - 23 Studies Found

Status Study
Completed Study Name: Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease
Condition: Graft vs Host Disease
Date: 2012-11-25
Interventions:
  • Drug: Tacrolimus D-1~D20: iv i
Completed Study Name: Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Condition: Graft vs Host Disease
Date: 2025-09-05
Interventions: Pacritinib will be given as 100 mg or 200 mg tablets to be taken orally twice daily (12 hours apart) on days 1-28 of a 28 day cycle.Morning and
COMPLETED Study Name: Photopheresis in GvHD After Hematopoietic Transplantation: Characteristics of the Procedure and of the Cell Product
Condition: Graft Vs Host Disease
Date: 2025-09-05
Interventions: ECP is performed by collecting leucocytes from the patient through leukopheresis and incubating them with 8-MOP and UVA in extracorporeal circulation.
<<< Previous